Castle Biosciences, Inc.
US ˙ NasdaqGM ˙ US14843C1053

SecurityCSTL / Castle Biosciences, Inc.
InstitutionDynamic Technology Lab Private Ltd
Latest Disclosed Ownership15,913 shares
Latest Disclosed Value $ 390,664
Dynamic Technology Lab Private Ltd ownership in CSTL / Castle Biosciences, Inc.

On May 15, 2026 - Dynamic Technology Lab Private Ltd filed a 13F-HR form disclosing ownership of 15,913 shares of Castle Biosciences, Inc. (US:CSTL) valued at $390,664 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 0 shares of Castle Biosciences, Inc.. The current value of the position is $343,721 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CASTLE BIOSCIENCES COM 14843C105 15,913 15,913 391 0.0635
2026-02-13 2025-12-31 13F CASTLE BIOSCIENCES COM 14843C105 0 -29,310 -100.00 0 -100.00
2025-11-13 2025-09-30 13F CASTLE BIOSCIENCES COM 14843C105 29,310 29,310 667 0.1130
2025-08-12 2025-06-30 13F CASTLE BIOSCIENCES COM 14843C105 0 -21,235 -100.00 0 -100.00
2025-05-16 2025-03-31 13F CASTLE BIOSCIENCES COM 14843C105 21,235 3,605 20.45 425 -9.57 0.0615
2025-02-13 2024-12-31 13F CASTLE BIOSCIENCES COM 14843C105 17,630 -26,264 -59.84 470 -62.46 0.0755
2024-11-13 2024-09-30 13F CASTLE BIOSCIENCES COM 14843C105 43,894 43,894 1,252 0.1325
2022-05-16 2022-03-31 13F CASTLE BIOSCIENCES COM 14843C105 0 -8,710 -100.00 0 -100.00
2022-02-14 2021-12-31 13F CASTLE BIOSCIENCES COM 14843C105 8,710 8,710 373 0.0413
2021-11-15 2021-09-30 13F CASTLE BIOSCIENCES COM 14843C105 0 -3,140 -100.00 0 -100.00
2021-08-13 2021-06-30 13F CASTLE BIOSCIENCES COM 14843C105 3,140 3,140 230 0.0231
2021-02-11 2020-12-31 13F CASTLE BIOSCIENCES COM 14843C105 0 -4,571 -100.00 0 -100.00
2020-11-13 2020-09-30 13F CASTLE BIOSCIENCES COM 14843C105 4,571 4,571 235 0.0378
2020-08-14 2020-06-30 13F CASTLE BIOSCIENCES COM 14843C105 0 -11,312 -100.00 0 -100.00
2020-05-13 2020-03-31 13F CASTLE BIOSCIENCES COM 14843C105 11,312 11,312 337 0.0657
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.